Mulley AG / Prostate-Specific Antigen Working Group / Radiation Therapy Oncology Group / / /
Event
Product Recall / Product Issues / /
Facility
American College of Physicians / /
IndustryTerm
therapy for clinically localized prostate cancer / /
MedicalCondition
androgen-independent prostate cancer / leukemia / hormone-refractory metastatic prostate cancer / advanced prostate cancer / Cancer / symptomatic hormone-resistant prostate cancer / hormone-refractory metastatic prostate carcinoma / Full Text Recurrent/Metastatic Disease / prostate cancer / early prostate cancer / flutamide withdrawal syndrome / hormone-refractory prostate cancer / advanced refractory prostate cancer / stage D1/pathologic node-positive adenocarcinoma / /
ASCO Classic Oncology References Prostate Cancer General References 1. Thompson IM, Ankerst DP, Chi C, et al. Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0